Keytruda (pembrolizumab) continued to enhance survival versus Yervoy (ipilimumab) in sufferers with unresectable stage 3 or 4 melanoma, as demonstrated by 10-year follow-up...
Dr. Jeffrey Wong defined that theranostics could also be one other accessible therapy choice.For sufferers with prostate most cancers, there are a lot...
